Pixavir marboxil

玛帕西沙韦

Report date: 2026/01/26 11:02:23
NME

Base Information

Drug NamePixavir marboxil
Drug Alias Name壹立康TG-1000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase acidic protein inhibitors
TargetsPolymerase acidic protein
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsInfluenza A virus infectionsInfluenza B virus infection
Approved Indications in ChinaInfluenza A virus infectionsInfluenza B virus infection
Original Approved Country/TerritoryMainland China
Original Approved Date2025/12/09
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTaiGen Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBoryung Biopharma Co LtdTaiGen Biotechnology Co LtdJoincare Pharmaceutical Group Industry Co Ltd
Inactive CompaniesTaigen Pharmaceutical R & D (Beijing) Co Ltd
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A